Renalytix plc (RENX) ORD GBP0.0025
- Add to watchlist
- Create an alert
- This stock can be held in a
29.00p
28.80p
145.00p
£34.71 million
29.00p
27.00p
10.25p
n/a
1.00p (3.33%) Previous:
1.00p
248,283
n/a
2,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 30/06/2023 | 30/06/2022 |
---|---|---|
Revenue ($m) | 3.40 | 2.97 |
Profit before tax ($m) | (46.22) | (49.63) |
Adjusted EPS (¢): | (56.00) | (78.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Renalytix surges on takeover approach
4 March 2024 11:28
-
Renalytix shares jump on draft US Medicare coverage decision
9 February 2024 10:38
-
Renalytix kidney test claims allowed by US Patent Office
6 October 2023 11:35
-
Form 8.5 (EPT/RI) - Renalytix plc
23 April 2024 12:00
-
Issue of Shares and Rule 2.9 Announcement
22 April 2024 17:27
-
Result of General Meeting
22 April 2024 16:09
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.